de la Cuadra-Grande A, Rejas J, Casado MA, Monroy M, Ruiz M
Quality of life measures in Parkinson’s disease: a systematic literature review of patient-reported outcomes measures (PROMs) and their psychometric properties
J Neurol. 2025;272(9):598. doi: 10.1007/s00415-025-13348-x
Ampudia-Blasco FJ, de la Cuadra-Grande A, Bellido-Castañeda V, Cebrián-Cuenca AM, Mezquita-Raya P, Carretero-Gómez J, Hernández Martínez AM, Oyagüez I, Gómez-Peralta F.
Cost analysis of the FreeStyle Libre systems in people with type 2 diabetes mellitus on basal insulin with poor glycemic control: a Spanish perspective
Diabetes Technol Ther. 2025. doi: 10.1177/15209156251363576
Cabezas J, Aguilera A, García F, Domínguez-Hernández R, Casado-Gómez A, Espinoza-Cámac N, Casado MA, Crespo J, Task Force Spanish Group for Comprehensive Hepatitis Diagnosis
Recommendations to practice: tracking the national rollout of comprehensive hepatitis diagnosis in Spain.
Rev Esp Enferm Dig. 2025;117. doi: 10.17235/reed.2025.11496/2025
Canut MI, García-Feijoo J, Larrosa-Poves JM, López-López F, Pazos, M,Espinoza-Cámac N, OyagüezI, Del Río T, Rodríguez M
Cost-utility analysis of latanoprost unidose cationic emulsion preservative-free versus latanoprost unidose in the treatment of open-angle glaucoma and ocular hypertension patients in Spain
Expert Rev Pharmacoecon Outcomes Res. 2025;25(9):1337-1343. doi: 10.1080/14737167.2025.2556693
Ortega González E, Domínguez-Hernández R, Martínez Roma M, Ocete-Mochone MD, Carrodeguas A, González-Sánchez JL, Casado MA, García Deltoro M
Value of public health interventions for HIV, HBV and HCV integrated screening: The FOCUS-CRIVALVIR programme
Ann Epidemiol. 2025;109:31-37. doi: 10.1016/j.annepidem.2025.06.014
Gil-Prieto R, Pérez-Martín J, Díaz Aguiló A, Soudani S, Platero-Alonso L, López-Belmonte JL, de la Cuadra-Grande A, Casado MA, Alvarez Aldean J